UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038883
Receipt number R000044259
Scientific Title Study for Monitoring the Impact of National HPV vaccinaTion program in Japan( Period II: April 2019-December 2026)
Date of disclosure of the study information 2019/12/16
Last modified on 2022/12/14 11:10:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study for Monitoring the Impact of National HPV vaccinaTion program in Japan( Period II : April 2019-December 2026)

Acronym

Monitoring the Impact of National HPV vaccinaTion program in Japan (MINT study II )

Scientific Title

Study for Monitoring the Impact of National HPV vaccinaTion program in Japan( Period II: April 2019-December 2026)

Scientific Title:Acronym

Monitoring the Impact of National HPV vaccinaTion program in Japan (MINT study II )

Region

Japan


Condition

Condition

Cervical cancer and its precursor lesions

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Monitoring the Impact of National HPV vaccination program in Japan

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The proportion of HPV16/18 positives among subjects of
cervical cancer, CIN2/3 and AIS in women aged 16-24, and 25-29 years

Key secondary outcomes

1. The number of women aged 16-24, and 25-29 years who contract cervical cancer,CIN2/3, AIS
2. The proportion of HPV16/18 positives among subjects of CIN1 in women aged 16-24, and 25-29 years
3. The proportion of HPV16/18 positives among subjects of cervical cancer, CIN2/3 and AIS in women aged 16-39 years
4. The distribution of HPV types among subjects of cervical cancer, CIN1/2/3, and AIS in women aged 16-39 years
5. The number of women aged 16-39 years who contract cervical cancer, CIN2/3, and AIS
6. The proportion of HPV16/18 positives among women aged 16-39 years with CIN1
7. The number of deaths from cervical cancer among women aged 16-39 years


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

40 years-old >

Gender

Female

Key inclusion criteria

All females, aged 16-39 years, who are newly diagnosed with cervical cancer, CIN, or AIS and have not yet been treated

Key exclusion criteria

Individuals in either of the groups listed below will be excluded as subjects of the research
1. Female patients younger than 16 or older than 39 years
2. Female who do not have CIN, AIS or cervical cancer

Target sample size

4000


Research contact person

Name of lead principal investigator

1st name Koji
Middle name
Last name Matsumoto

Organization

Showa University School of Medicine

Division name

Department of Obstetrics and Gynecology

Zip code

142-8666

Address

1-5-8 Hatanodai, Shinagawa-ku, Tokyo

TEL

03-3784-8551

Email

matsumok@mui.biglobe.ne.jp


Public contact

Name of contact person

1st name Yoshitaka
Middle name
Last name Yamaguchi

Organization

Showa University School of Medicine

Division name

Ethics Comittee

Zip code

142-8555

Address

1-5-8 Hatanodai, Shinagawa-ku, Tokyo

TEL

03-3784-8129

Homepage URL


Email

m-rinri@ofc.showa-u.ac.jp


Sponsor or person

Institute

Showa University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Dvelopment( AMED)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Showa University School of Medicine

Address

1-5-8 Hatanodai, Shinagawa-ku, Tokyo

Tel

03-3784-8551

Email

monuki@med.showa-u.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

19fk0108098

Org. issuing International ID_1

Japan Agency for Medical Research and Dvelopment( AMED)

Study ID_2

22fk0108651h0001

Org. issuing International ID_2

Japan Agency for Medical Research and Dvelopment( AMED)

IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 12 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 04 Month 01 Day

Date of IRB

2019 Year 07 Month 16 Day

Anticipated trial start date

2019 Year 07 Month 25 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Proactive long-term epidemiological joint research conducted at multiple facilities


Management information

Registered date

2019 Year 12 Month 13 Day

Last modified on

2022 Year 12 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044259


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name